NCT02483455View on ClinicalTrials.gov

ALC-919 For The Treatment Of Common Warts

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Verruca Vulgaris
Interventions
DRUG

2014-ALC-919-US

A topical solution to be applied twice daily for the treatment of Common Warts

DRUG

Vehicle-Control Topical Solution

A topical solution to be applied twice daily for the treatment of Common Warts

Trial Locations (1)

19034

Philadelphia Institute of Dermatology, Fort Washington

All Listed Sponsors
lead

Veloce BioPharma LLC

INDUSTRY

NCT02483455 - ALC-919 For The Treatment Of Common Warts | Biotech Hunter | Biotech Hunter